Author

Erika Yara Romero

Institute of Cancer ResearchORCID 0009-0002-7557-9128Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Assay:organoid / primary culture· 1 Assay:scATAC-seq· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrea SottorivaiD· 2 shared Trevor A. GrahamiD· 2 shared Ahmet AcariD· 1 shared Alex GraudenziiD· 1 shared Andrea BertottiiD· 1 shared Ann‐Marie BakeriD· 1 shared Bingjie CheniD· 1 shared Calum GabbuttiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrea SottorivaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedJun 20, 2025

Quantitative measurement of phenotype dynamics during cancer drug resistance evolution using genetic barcoding

Frederick J.H. Whiting, Maximilian Mossner, Calum Gabbutt…·Trevor A. Graham

This paper develops a mathematical framework to infer cancer drug resistance dynamics from genetic lineage tracing and population size data, validated using experimental evolution and single-cell sequencing.

8 citationstop 3%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedJun 11, 2025

Epigenetic heritability of cell plasticity drives cancer drug resistance through one-to-many genotype to phenotype mapping

Erica Aparecida de Oliveira, Salvatore Milite, Javier Fernández-Mateos…·Andrea Sottoriva

The paper shows how epigenetic heritability of cell plasticity contributes to cancer drug resistance through a one-to-many genotype-to-phenotype mapping.

51 citationstop 1%

humanorganoid / primary culture

𝕏 PostBluesky